Scroll Down

The future of precision medicine starts here

Our mission is to develop targeted microbiome-based therapeutics and molecular diagnostic tools to prevent and treat diseases of high unmet medical need

See Our Pipeline
 
 

Developing better therapies through a deep understanding of human microbial ecology

Siolta Therapeutics is a clinical-stage biopharmaceutical company developing targeted live biotherapeutic products to prevent and treat diseases of high unmet medical need. By leveraging our proprietary Precision Symbiotics Platform™ and in-house GMP-manufacturing capabilities, we are rapidly expanding our product pipeline into new indications with multiple programs in preclinical and clinical-stage development.

Our Platform